AVR anteris technologies global corp.

6.09%

$6.27

Will we see another Cap Raise before the 4C is out?, page-22

First 22 Last

Share
Profile

Follow
redant

3,216 Posts.

252

20/01/22

10:41

Post #: 59001080
Share

Originally posted by WilliamPike: ↑

Despite the proviso that I know nothing about this market, it seems to me that
1. We already manufacture this device(s)
2. Ramping up production can't be that hard.
3. Mark up is very high.
4. Every doctor in this market worth his salt knows about AVR.
5. If we began to market in say New York alone it would be a big business.
6. Expansion, if all is as advertised, would be exponentially rapid, and could be done out of cash flow.
I am wary of big shots who talk in millions in marketing costs. They are thinking of their pay in my view. I can't see the need. To digress a little I was concerned when we employed was it a director whose expertise was in M and A. Clearly they like doing what they are good at whether or not it is good for us. I think similarly about big shot marketing gurus. I am wary of anyone who breathes his own smoke.
To wrap up, we can do this. Even if we sell out later we have at least established profitability .
I would be very happy however to not pay tax on capital gains and live off the dividends
Just dreaming here....

Expand

"I would be very happy however to not pay tax on capital gains and live off the dividends"
My sentiments as well William. In relation to manufacturing of the valve the company has already signaled it's intentions in this regard in the announcement of the extension of the manufacturing agreement with Le Maitre -

AVR Price at posting: $18.52 Sentiment: Buy Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

AII

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

RMX

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

MVF

Monash IVF shares cater 25% – Disaster or deep-value play?

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

First 22 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $6.27		Change 0.360(6.09%)		Mkt cap ! $97.17M

Open	High	Low	Value	Volume
$5.93	$6.30	$5.91	$107.9K	17.39K

Buyers (Bids)

No.	Vol.	Price($)
1	3500	$6.12

Sellers (Offers)

Price($)	Vol.	No.
$6.27	200	1

View Market Depth

No.	Vol.	Price($)
1	3500	6.120
1	2000	6.100
1	1250	5.950
1	857	5.830
1	900	5.780

Price($)	Vol.	No.
6.300	463	1
6.400	130	1
6.500	255	1
6.550	1092	1
6.600	320	1

Last trade - 15.42pm 27/06/2025 (20 minute delay)

AVR (ASX) Chart

Will we see another Cap Raise before the 4C is out?, page-22

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Will we see another Cap Raise before the 4C is out?, page-22

Top Stories

Week 26 Wrap: Renewable gas fantasies; RBA July cut hope builds; copper's August peak?

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Red Mountain: Chip samples point to 'large orogenic antimony mineral system' at Oaky Creek

HotCopper Highlights Week 26: Droneshield 2.0; Trigg re-jig & Virgin

Monash IVF shares cater 25% – Disaster or deep-value play?

Australia’s gas crisis is here – and dying coal plants aren’t helping

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News